South Africa has asked the Serum Institute of India to take back the one million COVID-19 vaccine doses the company had sent in early February, a week after the country said it will put on hold the use of AstraZeneca's shot in its vaccination program, APA reports citing Reuters.
Serum Institute of India, which is producing AstraZeneca's shot, has emerged as a key vaccine supplier. One million doses of the COVID-19 vaccine landed in South Africa last week and another 500,000 were due to arrive in the next few weeks.
South Africa's health minister has said the government may sell doses of AstraZeneca's vaccine, after the country paused its rollout following a small clinical trial that showed it offered minimal protection against mild to moderate illness from the 501Y.V2 coronavirus variant dominant in the country.
Follow us on Telegram
t.me/apanewsaz
Follow us on Instagram
Follow us on Facebook
Follow us on Twitter
